Last 12 months
Inside the activity.
0 purchase rows · 14 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 6 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 01, 2003 Filed Jul 2, 2003 20:23 UTC |
DAYEM HASSANSr. V.P. & Chief Info. Officer
|
GrantISO (Right to Buy) · Derivative | 1,518 | $0.00 Strike: $65.85 | $0.00 |
DisclosureSEC source: 0001181431-03-012807 · rrd11641.xml · derivative · entry 1 DAYEM HASSAN · CIK 0001185619 · Sr. V.P. & Chief Info. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,518 Underlying: Common Stock · 1,518 shares Expires 2010-07-01 F2 · price: 0 Read SEC document |
| July 01, 2003 Filed Jul 2, 2003 20:22 UTC |
FENTON DENNIS MExecutive Vice President
|
GrantNQSO (Right to Buy) · Derivative | 148,482 | $0.00 Strike: $65.85 | $0.00 |
DisclosureSEC source: 0001181431-03-012803 · rrd11677.xml · derivative · entry 2 FENTON DENNIS M · CIK 0001184627 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 148,482 Underlying: Common Stock · 148,482 shares Expires 2010-07-01 F2 · price: 0 F1 · derivative.exercise_date: (DMF-07/03-NQSO) The option becomes exercisable for 30,000 shares on July 1, 2004: 30,000 shares on July 1, 2005; 30,000 shares on July 1, 2006; 30,000 shares on July 1, 2007; and 28,482 shares on July 1, 2008, respectively. Read SEC document |
| July 01, 2003 Filed Jul 2, 2003 20:22 UTC |
FENTON DENNIS MExecutive Vice President
|
GrantISO (Right to Buy) · Derivative | 1,518 | $0.00 Strike: $65.85 | $0.00 |
DisclosureSEC source: 0001181431-03-012803 · rrd11677.xml · derivative · entry 1 FENTON DENNIS M · CIK 0001184627 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,518 Underlying: Common Stock · 1,518 shares Expires 2010-07-01 F2 · price: 0 Read SEC document |
| July 01, 2003 Filed Jul 2, 2003 20:21 UTC |
MCNAMEE BRIAN MSr. V.P. Human Resources
|
GrantNQSO (Right to Buy) · Derivative | 98,482 | $0.00 Strike: $65.85 | $0.00 |
DisclosureSEC source: 0001181431-03-012801 · rrd11680.xml · derivative · entry 2 MCNAMEE BRIAN M · CIK 0001183885 · Sr. V.P. Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,482 Underlying: Common Stock · 98,482 shares Expires 2010-07-01 F2 · price: 0 F1 · derivative.exercise_date: (BMM-07/03-NQSO) The option becomes exercisable for 20,000 shares on July 1, 2004; 20,000 shares on July 1, 2005; 20,000 shares on July 1, 2006; 20,000 shares on July 1, 2007; and 18,482 shares on July 1, 2008, respectively. Read SEC document |
| July 01, 2003 Filed Jul 2, 2003 20:21 UTC |
MCNAMEE BRIAN MSr. V.P. Human Resources
|
GrantISO (Right to Buy) · Derivative | 1,518 | $0.00 Strike: $65.85 | $0.00 |
DisclosureSEC source: 0001181431-03-012801 · rrd11680.xml · derivative · entry 1 MCNAMEE BRIAN M · CIK 0001183885 · Sr. V.P. Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,518 Underlying: Common Stock · 1,518 shares Expires 2010-07-01 F2 · price: 0 Read SEC document |
| July 01, 2003 Filed Jul 2, 2003 20:20 UTC |
PERLMUTTER ROGER MExec VP Research & Development
|
GrantNQSO (Right to Buy) · Derivative | 148,482 | $0.00 Strike: $65.85 | $0.00 |
DisclosureSEC source: 0001181431-03-012798 · rrd11684.xml · derivative · entry 2 PERLMUTTER ROGER M · CIK 0001184228 · Exec VP Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,482 Underlying: Common Stock · 148,482 shares Expires 2010-07-01 F2 · price: 0 F1 · derivative.exercise_date: (RMP-07/03-NQSO) The option becomes exercisable for 30,000 shares on July 1, 2004; 30,000 shares on July 1, 2005; 30,000 shares on July 1, 2006; 30,000 shares on July 1, 2007; and 28,482 shares on July 1, 2008, respectively. Read SEC document |
| July 01, 2003 Filed Jul 2, 2003 20:20 UTC |
PERLMUTTER ROGER MExec VP Research & Development
|
GrantISO (Right to Buy) · Derivative | 1,518 | $0.00 Strike: $65.85 | $0.00 |
DisclosureSEC source: 0001181431-03-012798 · rrd11684.xml · derivative · entry 1 PERLMUTTER ROGER M · CIK 0001184228 · Exec VP Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,518 Underlying: Common Stock · 1,158 shares Expires 2010-07-01 F2 · price: 0 Read SEC document |
| July 01, 2003 Filed Jul 2, 2003 20:19 UTC |
SCHEHR BARRY DVP Financial Ops & CAO
|
GrantNQSO (Right to Buy) · Derivative | 13,482 | $0.00 Strike: $65.85 | $0.00 |
DisclosureSEC source: 0001181431-03-012796 · rrd11687.xml · derivative · entry 2 SCHEHR BARRY D · CIK 0001186720 · VP Financial Ops & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,482 Underlying: Common Stock · 13,482 shares Expires 2010-07-01 F2 · price: 0 F1 · derivative.exercise_date: (BDS-07/03-NQSO) The option becomes exercisable for 3,000 shares on July 1, 2004;3,000 shares on July 1, 2005; 3,000 shares on July 1, 2006; 3,000 shares on July 1, 2007; and 1,482 shares on July 1, 2008, respectively. Read SEC document |
| July 01, 2003 Filed Jul 2, 2003 20:19 UTC |
SCHEHR BARRY DVP Financial Ops & CAO
|
GrantISO (Right to Buy) · Derivative | 1,518 | $0.00 Strike: $65.85 | $0.00 |
DisclosureSEC source: 0001181431-03-012796 · rrd11687.xml · derivative · entry 1 SCHEHR BARRY D · CIK 0001186720 · VP Financial Ops & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,518 Underlying: Common Stock · 1,518 shares Expires 2010-07-01 F2 · price: 0 Read SEC document |
| July 01, 2003 Filed Jul 2, 2003 20:18 UTC |
SEIDENBERG BETH CSr VP Development
|
GrantNQSO (Right to Buy) · Derivative | 98,482 | $0.00 Strike: $65.85 | $0.00 |
DisclosureSEC source: 0001181431-03-012795 · rrd11691.xml · derivative · entry 2 SEIDENBERG BETH C · CIK 0001184592 · Sr VP Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,482 Underlying: Common Stock · 98,482 shares Expires 2010-07-01 F2 · price: 0 F1 · derivative.exercise_date: (BCS-07/03-NQSO) The option becomes exercisable for 20,000 shares on July 1, 2004; 20,000 shares on July 1, 2005; 20,000 shares on July 1, 2006; 20,000 shares on July 1, 2007; and 18,482 shares on July 1, 2008, respectively. Read SEC document |
| July 01, 2003 Filed Jul 2, 2003 20:18 UTC |
SEIDENBERG BETH CSr VP Development
|
GrantISO (Right to Buy) · Derivative | 1,518 | $0.00 Strike: $65.85 | $0.00 |
DisclosureSEC source: 0001181431-03-012795 · rrd11691.xml · derivative · entry 1 SEIDENBERG BETH C · CIK 0001184592 · Sr VP Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,518 Underlying: Common Stock · 1,518 shares Expires 2010-07-01 F2 · price: 0 Read SEC document |
| July 01, 2003 Filed Feb 28, 2006 20:37 UTC |
FENTON DENNIS MExecutive V.P., Operations
|
Exercise / conversionNQSO (Right to Buy) · Derivative | 20,000 | $38.36 Strike: $38.36 | $767,200.00 |
DisclosureSEC source: 0001181431-06-014884 · rrd109409.xml · derivative · entry 6 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 127,391 Underlying: Common Stock · 20,000 shares Expires 2009-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 13, 2003 Filed Jun 16, 2003 18:20 UTC |
SHARER KEVIN WDirector · Chairman of the Bd, CEO & Pres
|
Exercise / conversionISO (Right to Buy) · Derivative | 7,172 | $0.00 Strike: $13.94 | $0.00 |
DisclosureSEC source: 0001181431-03-010887 · rrd11106.xml · derivative · entry 2 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,172 shares Expires 2003-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 13, 2003 Filed Jun 16, 2003 18:20 UTC |
SHARER KEVIN WDirector · Chairman of the Bd, CEO & Pres
|
Exercise / conversionCommon Stock | 7,172 | $13.94 | $99,959.75 |
DisclosureSEC source: 0001181431-03-010887 · rrd11106.xml · nonDerivative · entry 1 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,204 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Note: 1 (KWS 6.13.03) Does not include 48,615 shares held as indirect ownership by the Family Trust. Read SEC document |
| June 03, 2003 Filed Jun 4, 2003 17:31 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 3,000 | $64.05 | $192,150.00 |
DisclosureSEC source: 0001181431-03-009882 · rrd10457.xml · nonDerivative · entry 4 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 807,200 F1 · ownership.nature: Note: 1(FPJ-5/3/03) Shares held as indirect ownership by Asset Management Partners ("AMP") for which the reporting person is a general partner. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934. F2 · ownership.nature: Note: 2(FPJ-5/3/03) Does not include: (i) 1,122,429 shares held as direct ownership by report person; (ii) 4 units of contractual contingent payment rights held by AMP arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P.; and (iii) 938,816 shares held as indirect ownership by the spouse of reporting person. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| June 03, 2003 Filed Jun 4, 2003 17:31 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 3,000 | $63.92 | $191,760.00 |
DisclosureSEC source: 0001181431-03-009882 · rrd10457.xml · nonDerivative · entry 3 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 810,200 F1 · ownership.nature: Note: 1(FPJ-5/3/03) Shares held as indirect ownership by Asset Management Partners ("AMP") for which the reporting person is a general partner. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| June 03, 2003 Filed Jun 4, 2003 17:31 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 3,000 | $63.84 | $191,520.00 |
DisclosureSEC source: 0001181431-03-009882 · rrd10457.xml · nonDerivative · entry 2 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 813,200 F1 · ownership.nature: Note: 1(FPJ-5/3/03) Shares held as indirect ownership by Asset Management Partners ("AMP") for which the reporting person is a general partner. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| June 03, 2003 Filed Jun 4, 2003 17:31 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 2,744 | $63.80 | $175,067.20 |
DisclosureSEC source: 0001181431-03-009882 · rrd10457.xml · nonDerivative · entry 1 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 816,200 F1 · ownership.nature: Note: 1(FPJ-5/3/03) Shares held as indirect ownership by Asset Management Partners ("AMP") for which the reporting person is a general partner. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| May 29, 2003 Filed May 30, 2003 17:15 UTC |
JOHNSON FRANKLIN P JRDirector
|
GiftCommon Stock | 32,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-03-009404 · rrd10130.xml · nonDerivative · entry 1 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,122,429 F1 · balance_after: Note: 1 (FPJ 5/29/03) Does not include: (i) 938,816 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner the securities for purposes of Section 16 of the Securities Exchange Act of 1934; (ii) 818,944 shares held by Asset Management Partners ("AMP") for which the reporting persons is a general partner; and (iii) 4 units of contractural contingent payment rights held as indirect ownership by AMP arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
| May 15, 2003 Filed May 19, 2003 15:55 UTC |
JOHNSON FRANKLIN P JRDirector
|
OtherCommon Stock | 80,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-03-008044 · rrd9210.xml · nonDerivative · entry 13 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 938,816 F1 · kind: Note: 1 (FPJ-05/03-Dist.) On May 15, 2003, Asset Management Partners ("AMP") distributed 240,000 shares of Amgen common stock to the partners of the partnership. Accordingly, 80,000 shares were distributed to each of the reporting person and his wife, and 80,000 shares were distributed to the other partners. AMP, of which the reporting person is a general partner, holds 818,944 shares of Amgen common stock. The reporting person disclaims beneficial ownership of the securities held by AMP, and the reporting herein of such securities shall not be construed as an admission that the reporting person is the beneficial owner of any such securities for purposes of Section 16 of the Securities Exchange Act of 1934. F3 · balance_after: Note: 3 (FPJ cj 05/15/03) Includes 80,000 shares previously held by AMP and held as indirect ownership by the spouse of the reporting person. Shares were distributed by AMP on May 15, 2003 to the spouse of the reporting person in a transaction under rule 16(a)13. The reporting person disclaims beneficial ownership of the securities indicated and the reporting herein of such securities shall not be construed as an admission that the reporting person is the beneficial owner of any such securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| May 15, 2003 Filed May 19, 2003 15:55 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 1,000 | $62.64 | $62,640.00 |
DisclosureSEC source: 0001181431-03-008044 · rrd9210.xml · nonDerivative · entry 12 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 818,944 F2 · balance_after: Note: 2 (FPJ-05/15/03-Dist.) On May 15, 2003, Asset Management Partners ("AMP") distributed 240,000 shares of Amgen common stock to the partners of the partnership. Accordingly, 80,000 shares were distributed to each of the reporting person and his wife, and 80,000 shares were distributed to the other partners. AMP, of which the reporting person is a general partner, holds 818,944 shares of Amgen common stock. In addition, AMP holds indirectly 4 units of contractual contingent payment rights arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. The reporting person disclaims beneficial ownership of the securities held by AMP, and the reporting herein of such securities shall not be construed as an admission that the reporting person is the beneficial owner of any such securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| May 15, 2003 Filed May 19, 2003 15:55 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 1,800 | $62.62 | $112,716.00 |
DisclosureSEC source: 0001181431-03-008044 · rrd9210.xml · nonDerivative · entry 11 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 819,944 Read SEC document |
| May 15, 2003 Filed May 19, 2003 15:55 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 2,600 | $62.61 | $162,786.00 |
DisclosureSEC source: 0001181431-03-008044 · rrd9210.xml · nonDerivative · entry 10 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 821,744 Read SEC document |
| May 15, 2003 Filed May 19, 2003 15:55 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 2,400 | $62.60 | $150,240.00 |
DisclosureSEC source: 0001181431-03-008044 · rrd9210.xml · nonDerivative · entry 9 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 824,344 Read SEC document |
| May 15, 2003 Filed May 19, 2003 15:55 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 894 | $62.59 | $55,956.35 |
DisclosureSEC source: 0001181431-03-008044 · rrd9210.xml · nonDerivative · entry 8 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 826,744 Read SEC document |
| May 15, 2003 Filed May 19, 2003 15:55 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 3,100 | $62.59 | $194,029.00 |
DisclosureSEC source: 0001181431-03-008044 · rrd9210.xml · nonDerivative · entry 7 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 827,638 Read SEC document |
| May 15, 2003 Filed May 19, 2003 15:55 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 1,300 | $62.58 | $81,354.00 |
DisclosureSEC source: 0001181431-03-008044 · rrd9210.xml · nonDerivative · entry 6 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 830,738 Read SEC document |
| May 15, 2003 Filed May 19, 2003 15:55 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 500 | $62.57 | $31,285.50 |
DisclosureSEC source: 0001181431-03-008044 · rrd9210.xml · nonDerivative · entry 5 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 832,038 Read SEC document |
| May 15, 2003 Filed May 19, 2003 15:55 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 8,706 | $62.57 | $544,734.42 |
DisclosureSEC source: 0001181431-03-008044 · rrd9210.xml · nonDerivative · entry 4 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 832,538 Read SEC document |
| May 15, 2003 Filed May 19, 2003 15:55 UTC |
JOHNSON FRANKLIN P JRDirector
|
SaleCommon Stock | 2,700 | $62.56 | $168,912.00 |
DisclosureSEC source: 0001181431-03-008044 · rrd9210.xml · nonDerivative · entry 3 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 841,244 Read SEC document |
| May 15, 2003 Filed May 19, 2003 15:55 UTC |
JOHNSON FRANKLIN P JRDirector
|
OtherCommon Stock | 240,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-03-008044 · rrd9210.xml · nonDerivative · entry 2 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 843,944 F1 · kind: Note: 1 (FPJ-05/03-Dist.) On May 15, 2003, Asset Management Partners ("AMP") distributed 240,000 shares of Amgen common stock to the partners of the partnership. Accordingly, 80,000 shares were distributed to each of the reporting person and his wife, and 80,000 shares were distributed to the other partners. AMP, of which the reporting person is a general partner, holds 818,944 shares of Amgen common stock. The reporting person disclaims beneficial ownership of the securities held by AMP, and the reporting herein of such securities shall not be construed as an admission that the reporting person is the beneficial owner of any such securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| May 15, 2003 Filed May 19, 2003 15:55 UTC |
JOHNSON FRANKLIN P JRDirector
|
OtherCommon Stock | 80,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-03-008044 · rrd9210.xml · nonDerivative · entry 1 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,154,929 F1 · kind: Note: 1 (FPJ-05/03-Dist.) On May 15, 2003, Asset Management Partners ("AMP") distributed 240,000 shares of Amgen common stock to the partners of the partnership. Accordingly, 80,000 shares were distributed to each of the reporting person and his wife, and 80,000 shares were distributed to the other partners. AMP, of which the reporting person is a general partner, holds 818,944 shares of Amgen common stock. The reporting person disclaims beneficial ownership of the securities held by AMP, and the reporting herein of such securities shall not be construed as an admission that the reporting person is the beneficial owner of any such securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| May 05, 2003 Filed May 7, 2003 15:59 UTC |
JOHNSON FRANKLIN P JRDirector
|
GiftCommon Stock | 12,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-03-007025 · rrd8426.xml · nonDerivative · entry 1 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,074,929 F1 · balance_after: In addition to the 1,074,929 shares of Amgen Inc. Common Stock directly owned by reporting person following this reported transaction, amount of securities indirectly held include: F2 · balance_after: (a) 1,083,944 shares indirectly held by Asset management Partners for which the reporting person is a general partner. F3 · balance_after: (b) 858,816 shares held by Catherine Johnson, spouse of reporting person. The reporting person disclaims beneficial ownership of the securities indicated and the reporting herein of such securities shall not be construed as an admission that the reporting person is the beneficial owner of any such securities for purposes of Section 16 of the Securities Exchange Act of 1934. F4 · balance_after: (c) 4 units of contractual contingent payment rights held by Asset Management Partners arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
| October 21, 2001 Filed Feb 27, 2004 00:29 UTC |
SHARER KEVIN WDirector · Chairman of the BD CEO & Pres
|
GiftCommon Stock | 10 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-04-012287 · rrd34719.xml · nonDerivative · entry 2 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the BD CEO & Pres 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 19,303 F2 · kind: Gift to a family member. F3 · balance_after: Mr. Sharer owns directly 9,855 shares. Since the date of the reporting person's last ownership report, he transferred beneficial ownership of 9,855 shares directly held by him, 19,302 shares indirectly held by a family trust and employee stock options to purchase 1,062,354 shares of the Company's Common Stock to his ex-wife persuant to a domestic relations order. Read SEC document |
| February 28, 2001 Filed Feb 28, 2006 20:37 UTC |
FENTON DENNIS MExecutive V.P., Operations
|
Exercise / conversionNQSO (Right to Buy) · Derivative | 8,800 | $68.19 Strike: $68.19 | $600,050.00 |
DisclosureSEC source: 0001181431-06-014884 · rrd109409.xml · derivative · entry 7 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 0 Underlying: Common Stock · 8,800 shares Expires 2007-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 30, 2000 Filed Feb 27, 2004 00:29 UTC |
SHARER KEVIN WDirector · Chairman of the BD CEO & Pres
|
GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-04-012287 · rrd34719.xml · nonDerivative · entry 1 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the BD CEO & Pres 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 19,313 F1 · kind: Gift to the U.S. Naval Academy. F3 · balance_after: Mr. Sharer owns directly 9,855 shares. Since the date of the reporting person's last ownership report, he transferred beneficial ownership of 9,855 shares directly held by him, 19,302 shares indirectly held by a family trust and employee stock options to purchase 1,062,354 shares of the Company's Common Stock to his ex-wife persuant to a domestic relations order. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.